# Astrana Health (ASTH) — Analyst Forecast

ASTH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/asth/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 10 | 1 | 0 | 11 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $50.00 | $52.75 | $55.00 | 4 |

Last price $38.03 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 1, 2026 | Freedom Capital Markets | Maintained | Buy | $50.00 |
| Sep 15, 2026 | Oppenheimer | Initiated Coverage | Outperform | $53.00 |
| Aug 11, 2026 | Truist Securities | Maintained | Buy | $55.00 |
| Aug 7, 2026 | Barclays | Maintained | Overweight | $53.00 |
| Jul 14, 2026 | BTIG | Maintained | Buy | $65.00 |
| Jul 14, 2026 | TD Cowen | Maintained | Buy | $50.00 |
| Jun 2, 2026 | BTIG | Maintained | Buy | $50.00 |
| May 26, 2026 | Barclays | Upgraded | Equal-Weight → Overweight | $50.00 |
| May 14, 2026 | Truist Securities | Maintained | Buy | $47.00 |
| May 12, 2026 | TD Cowen | Maintained | Buy | $45.00 |
| May 11, 2026 | Barclays | Maintained | Equal-Weight | $37.00 |
| May 8, 2026 | BTIG | Maintained | Buy | $50.00 |
| May 8, 2026 | Needham | Maintained | Buy | $41.00 |
| Apr 15, 2026 | Baird | Maintained | Outperform | $40.00 |
| Mar 13, 2026 | Truist Securities | Maintained | Buy | $38.00 |
| Feb 2, 2026 | BTIG | Maintained | Buy | $40.00 |
| Dec 12, 2025 | Needham | Initiated Coverage | Buy | $28.00 |
| Nov 25, 2025 | Jefferies | Maintained | Buy | $37.00 |
| Nov 24, 2025 | Barclays | Maintained | Equal-Weight | $26.00 |
| Nov 10, 2025 | TD Cowen | Maintained | Buy | $35.00 |

## Frequently Asked Questions

### What is the price target for ASTH stock?

The average 12-month analyst price target for Astrana Health (ASTH) is $52.75, with a high estimate of $55.00 and a low of $50.00, across 4 analysts.

### Is ASTH a buy, sell, or hold?

Analysts covering Astrana Health currently average a Buy rating: 10 buy, 1 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ASTH?

The average price target of $52.75 implies 38.71% upside from the last price of $38.03.

### What is the latest analyst rating on ASTH?

On Oct 1, 2026, Freedom Capital Markets maintained Astrana Health at Buy with a price target of $50.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).